Case report: Familial glycogen storage disease type IV caused by novel compound heterozygous mutations in a glycogen branching enzyme 1 gene

Glycogen storage disease type IV (GSD IV), caused by a mutation in the glycogen branching enzyme 1 (GBE1) gene, is a rare metabolic disorder with an autosomal recessive inheritance that involves the liver, neuromuscular, and cardiac systems. Here, we reported a case of familial GSD IV induced by novel compound heterozygous mutations in GBE1. The proband (at age 1) and her younger brother (at age 10 months) manifested hepatosplenomegaly, liver dysfunction, and growth retardation at onset, followed by progressive disease deterioration to liver cirrhosis with liver failure. During the disease course, the proband presented rare intractable asymptomatic hypoglycemia. The liver pathology was in line with GSD IV. Both cases carried pathogenic compound heterozygous mutations in GBE1 mutations, i.e., a missense mutation (c.271T>A, p. W91R) in exon 2 and a deletion mutation in partial exons 3–7. Both mutations are first reported. The internationally pioneered split-liver transplantation was performed during progression to end-stage liver disease, and the patients had normal liver function and blood glucose after. This study broadens the mutation spectrum of the GBE1 gene and the phenotypic spectrum of GSD IV.

[1]  C. Dionisi-Vici,et al.  Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI , 2022, Orphanet Journal of Rare Diseases.

[2]  B. Geramizadeh,et al.  Liver transplantation in glycogen storage disease: a single-center experience , 2022, Orphanet Journal of Rare Diseases.

[3]  Min Liu,et al.  Liver Transplantation for Glycogen Storage Disease Type IV , 2021, Frontiers in Pediatrics.

[4]  F. de Boer,et al.  The potential of dietary treatment in patients with glycogen storage disease type IV , 2020, Journal of inherited metabolic disease.

[5]  S. South,et al.  Technical standards for the interpretation and reporting of constitutional copy number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) , 2019, Genetics in Medicine.

[6]  Lora J. H. Bean,et al.  Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants , 2019, Genetics in Medicine.

[7]  S. Lee,et al.  A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme Gene , 2018, Pediatric gastroenterology, hepatology & nutrition.

[8]  S. Dimauro,et al.  Branching enzyme deficiency: expanding the clinical spectrum. , 2014, JAMA neurology.

[9]  A. El-Hattab,et al.  Glycogen Storage Disease Type IV , 2013 .

[10]  Y. Chien,et al.  Association of the Congenital Neuromuscular Form of Glycogen Storage Disease Type IV With a Large Deletion and Recurrent Frameshift Mutation , 2012, Journal of child neurology.

[11]  Steven R. Martin,et al.  Systemic progression of type IV glycogen storage disease after liver transplantation. , 2010, Journal of pediatric gastroenterology and nutrition.

[12]  E. Lemyre,et al.  Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder , 2010, Journal of Inherited Metabolic Disease.

[13]  H. Ozen Glycogen storage diseases: new perspectives. , 2007, World journal of gastroenterology.

[14]  S. Dimauro,et al.  Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV) , 2004, Neurology.

[15]  T. Starzl,et al.  Liver transplantation for glycogen storage disease types I, III, and IV , 1999, European Journal of Pediatrics.